Further Investigation of the Negative Association between Hypertension and Peripheral Neuropathy in the Elderly: An Oklahoma Physicians Resource/Research Network (OKPRN) Study

References

1. ↵
   Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older subjects. J Am Board Fam Pract 2004; 17: 309–18.

   OpenUrlCrossRefPubMed
2. ↵
   Sendtner M. Molecular biology of neurotrophic factors. Baillieres Clin Neurol 1995; 4: 575–91.

   OpenUrlPubMed
3. ↵
   Lindsay RM. Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol Aging 1994; 15: 249–51.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352: 341–50.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   Forrest KYZ, Maser RE, Pambianco G, Becker DJ, Orchard TJ. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 1997; 46: 665–70.

   OpenUrlAbstract/FREE Full Text
6. ↵
   Zarrelli MM, Amoruso L, Beghi E, Apollo F, Viesti PD, Simone P; Italian General Practitioner Study Group. Arterial hypertension as a risk factor for chronic symmetric polyneuropathy. J Epidemiol Biostat 2001; 6: 409–13.

   OpenUrlCrossRefPubMed
7. ↵
   Teunissen LL, Franssen H, Wokke JHJ, et al. Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?. J Neurol Neurosurg Psychiatry 2002; 72: 590–5.

   OpenUrlAbstract/FREE Full Text
8. ↵
   Young MJ, Veves A, Walker MG, Boulton AJM. Correlations between nerve function and tissue oxygenation in diabetic subjects: further clues to the aetiology of diabetic neuropathy? Diabetologia 1992; 35: 1146–50.

   OpenUrlCrossRefPubMedWeb of Science
9. Hogikyan RV, Wald JJ, Feldman EL, Greene DA, Halter JB, Supiano MA. Acute effects of adrenergic-mediated ischemia on nerve conduction in subjects with type 2 diabetes. Metabolism 1999; 48: 495–500.

   OpenUrlPubMed
10. Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989; 32: 92–102.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Hammersley V, Hippisley-Cox J, Wilson A, Pringle M. A comparison of research general practices and their patients with other practices—a cross-sectional survey in Trent. Br J Gen Pract 2002; June: 463–8.
12. Stange KC. Practice-Based Research Networks—their current level of validity, generalizability, and potential for wider application. Arch Fam Med 1993; 2: 921–3.

    OpenUrlCrossRefPubMed
13. Green LA, Miller RS, Reed FM, Iverson DC, Barley GW. How representative of typical practice are practice-based research networks? A report from the Ambulatory Sentinel Practice Network Inc. (ASPN). Arch Fam Med 1993; 2: 939–49.

    OpenUrlCrossRefPubMed
14. ↵
    Page GD, France CR. Identifying hypertension using the Ohio Blood Pressure History Survey. Mil Med 2001; 166: 233–6.

    OpenUrlPubMedWeb of Science
15. ↵
    Kehoe R, Wu SY, Leske MC, Chylack LT Jr. Comparing self-reported and physician-reported medical history. Am J Epidemiol 1994; 139: 813–8.

    OpenUrlAbstract/FREE Full Text
16. ↵
    Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med 2003; 163: 681–7.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    England JD, Gronseth GS, Franklin G, et al. Distal symmetric polyneuropathy: a definition for clinical research—report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005; 64: 199–207.

    OpenUrlAbstract/FREE Full Text
18. ↵
    Dyck PJ, Oviatt KF, Lambert EH, et al. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984; 47: 530–5.

    OpenUrlAbstract/FREE Full Text
19. ↵
    Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981; 10: 222–6.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Joseph DS. The art and science of bedside diagnosis. Baltimore (MD): Urban & Schwarzenberg; 1990. p. 501.
21. Waal-Manning HJ. Effect of propranolol on the duration of the Achilles tendon reflex. Clin Pharmacol Ther 1969; 10: 199–206.

    OpenUrlPubMed
22. Marsden CD, Gimlette TMD, McAllister RG, Owen DAL, Miller TN. Effect of β-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic subjects. Acta Endocrinol 1968; 57: 353–62.

    OpenUrlAbstract/FREE Full Text
23. ↵
    Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987; 147: 1442–4.

    OpenUrlCrossRefPubMedWeb of Science